Veterinary Medicine Is Becoming Family Medicine. Is Mexico Ready?

At veterinary conferences, public forums, and conversations with pet owners, I have noticed a meaningful shift. We have all seen it, I’m sure. People are no longer asking only where to buy a product or whether a treatment “works.” They are asking more profound questions: How can I help my aging dog live with less pain? What can I do if my cat has stopped eating? Is there a way to treat this condition without creating another problem? How do I know whether a therapy or medication is safe? 

These are not consumer questions. They are healthcare questions, and ones we can no longer ignore. 

For years, the growth of the pet sector has been described mainly through consumption: premium food, accessories, grooming, boarding, and entertainment. But that description is certainly becoming incomplete. As dogs and cats (as well as “less conventional” pets, such as birds and lizards) become integral members of the household, families increasingly expect the same basic principles they value in human healthcare: prevention, accurate diagnosis, continuity of care, pain management, professional guidance, and dignity at the end of life. 

This does not mean treating animals as humans, as much as some of these tendencies are headed that way. What it means is recognizing that emotional attachment creates responsibility: a family that considers an animal part of its home will naturally seek better answers when that animal develops diabetes, kidney disease, cancer, chronic pain, anxiety, dermatological conditions, or age-related decline. 

The veterinary sector must therefore evolve from a pet-products market into a true companion-animal healthcare ecosystem. The question is whether our infrastructure, as well as our health professionals, veterinarians in this case, are evolving at the same speed. For example, veterinary professionals today are expected to manage increasingly complex cases. They must communicate with “highly informed” pet owners, or at least pet owners that are concerned enough to research first, regardless if the information they get is correct or not. 

Veterinarians also need to interpret new scientific information, evaluate products promoted directly to consumers, coordinate diagnostic services, and make treatment decisions across species, breeds, ages, and body sizes. They are also expected to address nutrition, behavior, rehabilitation, chronic disease, and palliative care, often within fragmented systems and under considerable economic pressure. 

The problem is not a lack of committed veterinarians. On the contrary, Mexico has highly capable professionals. The concern is that many of them are being asked to deliver “21st-first-century care” with systems that remain unevenly developed: access to specialists is still inconsistent; clinical records are not always interoperable or complete; referral pathways between primary care, diagnostics, hospitals, and specialty practices are frequently informal. 

One of the more alarming trends is that pet owners frequently self-medicate animals using human products, online recommendations, or substances obtained through informal markets. So, in most cases, the veterinarian must correct misinformation before even beginning the clinical conversation. 

This is where infrastructure matters. A serious veterinary healthcare ecosystem requires more than clinics. It requires continuing professional education, reliable laboratories, traceable pharmaceutical products, structured referral networks, better clinical data, ethical communication, and clearer coordination among regulators, universities, industry, and practitioners. It also requires economic tools that make care more accessible, including preventive plans, insurance models, financing options, and more efficient supply chains. 

Mexico is not starting from zero. The country’s legal framework already recognizes animal welfare, veterinary services, and the regulation of pharmaceutical, biological, chemical, and nutritional products for animal use. It also places the veterinarian at the center of preventive programs, prescription, dosing, and treatment supervision. The challenge is not simply creating more rules. It is translating existing principles into consistent clinical practice, stronger institutions, and better access. 

One area where existing healthcare infrastructure can make an immediate difference is compounded medicine. Veterinary patients are inherently diverse. A 5kg cat, a Chihuahua, and a 30kg Labrador cannot be treated as interchangeable units simply because they share a diagnosis. Species, breed, metabolism, age, organ function, comorbidities, tolerance, palatability, and the ability to swallow a tablet all influence treatment. Commercially manufactured medicines remain essential, but standardized presentations do not always meet every patient’s needs. 

Under appropriate professional and pharmaceutical controls, compounded medicine can help adjust concentration, dosage form, excipients, flavor, and route of administration for an individual animal. It can improve adherence, reduce dosing errors, and make treatment feasible when an available presentation is unsuitable. Compounded veterinary medicine, just as human compounding medications, should be built on prescription, professional judgment, traceable ingredients, adequate preparation controls, proper labeling, documentation, and follow-up. The value of personalization lies not in lowering the standard, but in increasing precision. Personalized veterinary medicine should mean greater clinical flexibility accompanied by greater responsibility. 

The transformation of veterinary health also represents a significant business and policy opportunity: Mexico can develop stronger capabilities in diagnostics, specialty hospitals, teleconsultation, clinical education, rehabilitation, nutrition, pharmaceutical development, compounded medicine, palliative care, insurance, and data systems. These are not isolated commercial categories. Together, they form the infrastructure of a more mature veterinary health economy. 

For companies, this means moving beyond selling products and toward supporting outcomes. For regulators, it means distinguishing clearly among medicines, supplements, foods, and informal therapeutic claims. For universities, it means preparing veterinarians for chronic disease, geriatric care, emerging therapies, client communication, and interdisciplinary practice. For practitioners, it means gaining access to better tools without losing clinical independence. And for families, it means receiving clearer information and safer options. 

If we truly accept that companion animals occupy a central place in millions of households, then veterinary care cannot remain an afterthought within the broader healthcare conversation. It deserves investment, regulation, education, innovation, and professional infrastructure proportional to the responsibility families have assumed. 

The goal should not be to copy human medicine in every detail. Veterinary medicine has its own science, ethics, economics, and clinical realities. But it should adopt the same seriousness with which we approach quality, prevention, evidence, continuity, and patient safety. 

The fact that animals have become family members should not simply create a larger consumer market. It should create a higher standard of care. And we, in Mexico, have the opportunity to build that standard.